Previous Page  13 / 31 Next Page
Information
Show Menu
Previous Page 13 / 31 Next Page
Page Background

Page 49

Notes:

conferenceseries

.com

Volume 7, Issue 1 (Suppl)

J Biotechnol Biomater

ISSN: 2155-952X JBTBM, an open access journal

March 20-21, 2017 Rome, Italy

&

15

th

World Congress on

2

nd

International Conference on

Biotechnology And Biotech Industries Meet

Enzymology and Molecular Biology

Enzymology & Mol. Biology 2017

Biotechnology Congress 2017

March 20-21, 2017

Microbial bioconversions of biologically active P-C compounds: Scope and limitations of scaling-up

Ewa Żymanczyk-Duda

Wroclaw University of Science and Technology, Poland

C

hirality is a crucial feature in the world of living organisms. This is responsible for the specific interactions between biologically

active compounds in nature; therefore, it is also fundamental for designing the novel compounds. Among P-C compounds,

structures are phosphonate derivatives such as amino phosphonates, keto phosphonates, hydroxy phosphonates. These are analogues

of physiological compounds, so they are applied as moderators of activity of particular enzymes involved in natural compounds

metabolic pathways. For such purposes, it is necessary to receive them as defined optical isomers. Chemical synthesis of such

phosphonates is of low-effectiveness, also for the economic reasons, so biocatalytical approach appeared to be a good alternative.

Good results were achieved for the kinetic resolutions of the racemic mixtures of amino- and hydroxy-phosphonates. This was

performed via selective oxidation and employing following fungal genera:

Penicillium, Beauveria, Cunninghamella, Verticillium,

Cladosporium, Rhodotorula

and

Saccharomyces

(as whole-cells biocatalysts). The same fungal mycelia were able to selectively reduce

(thermodynamic process) prochiral keto phosphonates. The above mentioned experiments succeeded based on the laboratory scale

and the most effective ones were selected for scaling- up process. This was the hardest part, because it required the modifications

of the biotransformation procedures and the biocatalyst form. Experiments were performed with the use of batch and continuous

reactors, and the fungal mycelia were immobilized with the use of polyurethane foams.

Biography

Ewa Żymanczyk-Duda has done his MSc in Biotechnology (1990), PhD in Chemistry (1995) from Wroclaw University of Science and Technology, Poland. She has

also worked as an Assistant Professor (2008) at the Wroclaw University of Science and Technology, Poland. She was the Vice Dean of Chemistry Department,

Coordinator of Teaching Program in the area of Biotechnology. She has published more than 40 papers in reputed journals and has been serving as a reviewer

for various journals.

ewa.zymanczyk-duda@pwr.edu.pl

Ewa Żymanczyk-Duda, J Biotechnol Biomater 2017, 7:1(Suppl)

http://dx.doi.org/10.4172/2155-952X.C1.070